THURSDAY, March 12, 2026 (HealthDay News) Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government
doi: 10.1155/2018/7801543
BV improved reproductive performance and semen antioxidant activity
De Jong stated: At the end of the trial patients in the psilocybin group had far less side effects, less suicidal ideation and so on. And in May, a phase three trial into MDMA for PTSD patients suggested MDMA-assisted therapy will be an effective treatment for severe, chronic PTSD
The drug is known generically as liraglutide, which the FDA says has been in short supply with certain other GLP-1 medications. This references the consistent shortages for drugs like semaglutides, known by brand names such as Ozempic and Wegovy, and tirzepatides, with brand names like Zepbound and Mounjaro
[DOI] [PMC free article] [PubMed] [Google Scholar] 207.Ooi S.L., Green R., Pak S.C